ZYXI
Zynex, Inc.
Set alert
- YTD
- -98.44%
- 1 year
- -98.48%
- Open
- 0.125
- Prev close
- 0.125
- Mkt cap
- 261.77M
- Vol
- 274.57K
- Avg vol
- 90.03K
- EPS
- 0.14
- P/E
- 58.71
- Div yield
- 0.00%
More statistics
- Low
- 0.125
- High
- 0.125
- Forward P/E
- 17.13
- Beta
- 0.54
- Short ratio
- 54.23
- Inst. own
- 28.01%
- Dividend
- 0.00
- Ex-div date
- Jan 4, 2022
- Earnings
- Nov 30, 2019
- 50-d avg
- 8.33
- 200-d avg
- 9.39
- 1y target
- 17.50
Key statistics
- Market cap
- 261.77M
- Enterprise value
- 299.78M
- Trailing P/E
- 58.71
- Forward P/E
- 17.13
- PEG ratio
- 0.00
- Price / sales
- 1.35
- Price / book
- 7.31
- EPS (TTM)
- 0.14
- Beta
- 0.54
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 2.49%
- Revenue (TTM)
- 193.66M
- Revenue growth
- 0.10%
- Free cash flow
- 19.76M
- Total cash
- 37.63M
- Total debt
- 74.68M
- Return on equity
- 10.22%
- Shares outstanding
- 31.85M
- Short % of float
- 30.88%
- 50-day average
- 8.33
- 200-day average
- 9.39
Analyst view
Consensus: none
- Target (low)
- 11.00
- Target (mean)
- 17.50
- Target (high)
- 24.50
- Strong buy2
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 30, 2019
Expected Nov 30, 2019. Consensus EPS estimate 0.09.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 30, 2019 | Dec 1, 2010 | 0.00 | — | — | — |
| Nov 10, 2016 | Sep 1, 2016 | 0.00 | 0.02 | — | — |
| Aug 22, 2016 | Jun 1, 2016 | 0.00 | -0.01 | — | — |
| May 19, 2016 | Mar 1, 2016 | 0.00 | -0.01 | — | — |
| Mar 31, 2016 | Dec 1, 2015 | 0.00 | -0.04 | — | — |
| Nov 17, 2015 | Sep 1, 2015 | 0.00 | -0.01 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 6, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Oct 25, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Oct 8, 2024 | RBC Capital | main | Outperform | Outperform |
| Sep 4, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| Jul 26, 2024 | RBC Capital | main | Outperform | Outperform |
| Jul 26, 2024 | HC Wainwright & Co. | main | Buy | Buy |
About Zynex, Inc.
Zynex, Inc., together with its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography and electric stimulation technology device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; E-Wave, an NMES device; M-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and braces for rehabilitation support. Further, it offers Zynex Fluid Monitoring System (CM-1500); Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring and intravascular volume monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Country
- United States
- Website
- zynex.com
News
- Critical Survey: Zynex (NASDAQ:ZYXI) versus Tactile Systems Technology (NASDAQ:TCMD)
- Head to Head Survey: Zynex (NASDAQ:ZYXI) & Cytosorbents (NASDAQ:CTSO)
- Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm
- Kuehn Law Encourages Investors of Zynex, Inc. to Contact Law Firm
- ZYXIQ CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
- Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Zynex, Inc. Lawsuit – ZYXIQ
- Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
- Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
- ZYXIQ SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026
- Bronstein, Gewirtz & Grossman LLC Urges Zynex, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Your note
Sign in to keep a note on ZYXI — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CRESS MICHAEL D | Director | Stock Award(Grant) | May 15, 2024 | 22,587 |
| DISBROW JOSHUA R. | Director | Purchase | Jul 28, 2024 | 72,000 |
| LUCSOK ANNA | Chief Operating Officer | Stock Award(Grant) | Oct 28, 2024 | 96,137 |
| MICHAELS BARRY D | Director | Stock Award(Grant) | May 15, 2024 | 22,587 |
| MOORHEAD DANIEL J | Chief Financial Officer | Stock Award(Grant) | Dec 4, 2024 | 102,118 |
| SANDGAARD THOMAS | Chief Executive Officer | Sale | Nov 13, 2024 | 14,603,700 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 3.65% | 1,178,106 | 9.68M | Sep 29, 2024 |
| Blackrock Inc. | 3.63% | 1,171,790 | 9.63M | Sep 29, 2024 |
| Hotchkis & Wiley Capital Management, LLC | 2.32% | 746,380 | 6.14M | Sep 29, 2024 |
| Nantahala Capital Management, LLC | 1.52% | 490,000 | 4.03M | Sep 29, 2024 |
| Geode Capital Management, LLC | 1.32% | 425,509 | 3.50M | Sep 29, 2024 |
| State Street Corporation | 1.17% | 378,030 | 3.11M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 2.28% | 733,808 | 6.03M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 1.16% | 372,520 | 3.06M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 0.94% | 303,630 | 2.50M | Sep 29, 2024 |
| Hotchkis and Wiley Small Cap Diversified Value Fund | 0.63% | 202,200 | 1.66M | Sep 29, 2024 |
| Royce Micro-Cap Fund | 0.54% | 174,088 | 1.43M | Sep 29, 2024 |
| Fidelity Small Cap Index Fund | 0.48% | 155,062 | 1.27M | Aug 30, 2024 |